nitroglycerin has been researched along with Respiratory Distress Syndrome in 17 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of a patient with COVID-19 complicated by ARDS and bilateral pulmonary emboli with severe right ventricular dysfunction and systemic hypotension treated with nebulized nitroglycerin and systemic thrombolytic therapy in the ED." | 8.02 | COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure. ( Gill, J; Gordon, R; Karfunkle, B; Shirey, S, 2021) |
| " The two vasodilators were infused in ten patients with mild or moderate ARDS at a dosage rate achieving a 20% reduction of the mean arterial pressure." | 5.28 | Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. ( Becker, H; Falke, KJ; Radermacher, P; Santak, B, 1989) |
| "We present a case of a patient with COVID-19 complicated by ARDS and bilateral pulmonary emboli with severe right ventricular dysfunction and systemic hypotension treated with nebulized nitroglycerin and systemic thrombolytic therapy in the ED." | 4.02 | COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure. ( Gill, J; Gordon, R; Karfunkle, B; Shirey, S, 2021) |
| "Whether the pulmonary edema is cardiogenic or noncardiogenic, optimal management is facilitated by the improvement of ventilation and gas exchange within the lungs and the restoration of oxygen transport to peripheral tissues." | 2.36 | Acute alveolar edema. ( Nowakowski, JF, 1983) |
| "Reperfusion injury is a perplexing cause of early graft failure after lung transplantation and today we know that reperfusion may be more harmful to tissues than the preceding ischemia." | 1.33 | Beneficial effects of supplemental nitric oxide donor given during reperfusion period in reperfusion-induced lung injury. ( Demirel, R; Dilek, FH; Esme, H; Fidan, H; Solak, O; Unlu, M, 2006) |
| "Nitroglycerin and fluids were used to maintain tissue perfusion and prevent tissue hypoxia as reflected by transcutaneous oxygen tension values." | 1.29 | Intraoperative maintenance of tissue perfusion prevents ARDS. Adult Respiratory Distress Syndrome. ( Charbonnet, C; DeMeester, TR; Katz, R; Kuchta, K; Mikhail, MS; Roessler, P; Roffey, P; Shoemaker, WC; Thangathurai, D; Wo, CC; Zelman, V, 1996) |
| " The two vasodilators were infused in ten patients with mild or moderate ARDS at a dosage rate achieving a 20% reduction of the mean arterial pressure." | 1.28 | Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. ( Becker, H; Falke, KJ; Radermacher, P; Santak, B, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Karfunkle, B | 1 |
| Gill, J | 1 |
| Shirey, S | 1 |
| Gordon, R | 1 |
| Hodroge, SS | 1 |
| Glenn, M | 1 |
| Breyre, A | 1 |
| Lee, B | 1 |
| Aldridge, NR | 1 |
| Sporer, KA | 1 |
| Koenig, KL | 1 |
| Gausche-Hill, M | 1 |
| Salvucci, AA | 1 |
| Rudnick, EM | 1 |
| Brown, JF | 1 |
| Gilbert, GH | 1 |
| Huang, SH | 1 |
| Chang, SW | 1 |
| Wang, AY | 1 |
| Daxon, BT | 1 |
| Lark, E | 1 |
| Matzek, LJ | 1 |
| Fields, AR | 1 |
| Haselton, KJ | 1 |
| Lowson, SM | 1 |
| Esme, H | 1 |
| Fidan, H | 1 |
| Solak, O | 1 |
| Dilek, FH | 1 |
| Demirel, R | 1 |
| Unlu, M | 1 |
| Famularo, G | 1 |
| Galluzzo, M | 1 |
| Ianakiev, I | 1 |
| Veleva, M | 1 |
| Nikolov, N | 1 |
| Zurick, AM | 1 |
| Wagner, RH | 1 |
| Starr, NJ | 1 |
| Lytle, B | 1 |
| Estafanous, FG | 1 |
| Nowakowski, JF | 1 |
| Thangathurai, D | 1 |
| Charbonnet, C | 1 |
| Wo, CC | 1 |
| Shoemaker, WC | 1 |
| Mikhail, MS | 1 |
| Roffey, P | 1 |
| Roessler, P | 1 |
| Kuchta, K | 1 |
| Zelman, V | 1 |
| DeMeester, TR | 1 |
| Katz, R | 1 |
| Thompson, JS | 1 |
| Kavanagh, BP | 1 |
| Pearl, RG | 1 |
| Kummer, F | 1 |
| Annest, SJ | 1 |
| Rhodes, GR | 1 |
| Stratton, HH | 1 |
| Newell, JC | 1 |
| Powers, SR | 1 |
| Radermacher, P | 3 |
| Santak, B | 3 |
| Becker, H | 1 |
| Falke, KJ | 3 |
| Assmann, R | 1 |
3 reviews available for nitroglycerin and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Inhaled alternatives to nitric oxide.
Topics: Administration, Inhalation; Alprostadil; Animals; Epoprostenol; Humans; Hypertension, Pulmonary; Ilo | 2002 |
[Treatment of shock lung].
Topics: Adenosine Triphosphate; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Arginine; Blood Pre | 1982 |
Acute alveolar edema.
Topics: Acute Disease; Adrenal Cortex Hormones; Altitude Sickness; Aminophylline; Anti-Arrhythmia Agents; Ca | 1983 |
14 other studies available for nitroglycerin and Respiratory Distress Syndrome
| Article | Year |
|---|---|
COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure.
Topics: COVID-19; Humans; Nitroglycerin; Pulmonary Embolism; Respiratory Distress Syndrome; SARS-CoV-2; Thro | 2021 |
Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Prehospital Care.
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; California; Dyspnea; Emergency Medical Services; Ho | 2020 |
Gynaecological transurethral resection of the prostate syndrome-induced acute pulmonary oedema treated with high-dose nitro-glycerine: a case report.
Topics: Acute Disease; Female; Humans; Hysteroscopy; Intraoperative Complications; Medical Illustration; Mid | 2020 |
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
Topics: COVID-19; COVID-19 Drug Treatment; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nitroglycer | 2021 |
Beneficial effects of supplemental nitric oxide donor given during reperfusion period in reperfusion-induced lung injury.
Topics: Analysis of Variance; Animals; Heart-Lung Transplantation; Lung; Lung Transplantation; Neutrophils; | 2006 |
Transfusion-related acute lung injury.
Topics: Aged; Anemia, Iron-Deficiency; Combined Modality Therapy; Erythrocyte Transfusion; Follow-Up Studies | 2007 |
Intravenous nitroglycerin, methemoglobinemia, and respiratory distress in a postoperative cardiac surgical patient.
Topics: Cardiac Surgical Procedures; Humans; Infusions, Parenteral; Male; Methemoglobinemia; Methylene Blue; | 1984 |
Intraoperative maintenance of tissue perfusion prevents ARDS. Adult Respiratory Distress Syndrome.
Topics: Adult; Aged; Fluid Therapy; Hemodynamics; Humans; Intraoperative Care; Middle Aged; Monitoring, Intr | 1996 |
Nitroglycerin does not alter pulmonary vascular permeability in isolated rabbit lungs.
Topics: Animals; Capillary Permeability; In Vitro Techniques; Lung; Male; Nitroglycerin; Organ Size; Oxidant | 1997 |
Old versus new: nitroglycerin versus NO?
Topics: Animals; Clinical Trials as Topic; Dogs; Humans; Infant, Newborn; Lung Diseases, Obstructive; Nitric | 1998 |
Increased intrapulmonary shunt following infusion of nitroglycerine or nitroprusside in patients with posttraumatic respiratory distress.
Topics: Adult; Ferricyanides; Hemodynamics; Humans; Lung; Nitroglycerin; Nitroprusside; Pulmonary Circulatio | 1979 |
Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome.
Topics: Adolescent; Adult; Alprostadil; Female; Humans; Male; Middle Aged; Nitroglycerin; Pulmonary Wedge Pr | 1989 |
Prostaglandin E1 and right ventricular function in ARDS.
Topics: Alprostadil; Humans; Infusions, Intravenous; Nitroglycerin; Respiratory Distress Syndrome; Stroke Vo | 1989 |
Comparison of prostaglandin E1 and nitroglycerin in patients with ARDS.
Topics: Alprostadil; Blood Pressure; Humans; Hypertension, Pulmonary; Nitroglycerin; Pulmonary Circulation; | 1989 |